World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10). Geneva: WHO; 2019.
[2]
American Academy of Neurology. Practice Parameter: The usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple mononeuropathy. Neurology. 2020.
[3]
Hughes RA. Systematic review of peripheral neuropathy in systemic autoimmune diseases. Autoimmunity Reviews. 2019;18(5):456-462.
[4]
Said G. Diabetic neuropathy. Handbook of Clinical Neurology. 2021;161:123-140.
[5]
Watson JC, Dyck PJ. Peripheral neuropathy: A practical approach to diagnosis and symptom management. Mayo Clinic Proceedings. 2020;90(7):940-951.
[6]
England JD, Gronseth GS, Franklin G, et al. Practice Parameter: Evaluation of distal symmetric polyneuropathy. Neurology. 2019;72(2):185-192.
[7]
Bourre-Tessier J, Piro F, Luthra F. Peripheral nervous system involvement in systemic lupus erythematosus. Current Rheumatology Reports. 2021;23(4):28.
[8]
Merkies IS, Faber CG, Lauria G. Advances in diagnostics and management of painful neuropathy. Nature Reviews Neurology. 2022;18(6):345-357.
[9]
Callaghan BC, Price RS, Feldman EL. Distal symmetric polyneuropathy: A review. JAMA. 2020;314(21):2172-2181.
[10]
Rajabally YA, Stettner M, Kieseier BC, et al. CIDP and its mimics. Journal of Neurology. 2021;268(9):3359-3369.